title: Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory.
abstract: BACKGROUND
  We evaluated the recent prevalence of serologic markers of hepatitis A virus (HAV) in South Korea.
  
  
  METHODS
  The study data were the results of 60 126 anti-HAV (total) tests and 30 786 anti-HAV IgM tests that were performed during April 2009 through March 2010 by the Eone Reference Laboratory at the request of 1935 institutions throughout Korea.
  
  
  RESULTS
  The overall positivity rate was 51.06% on the anti-HAV (total) test and 11.20% on the anti-HAV IgM test. As compared with the other age groups the rate of anti-HAV (total) positivity was significantly lower (P < 0.001), and the rate of anti-HAV IgM positivity was significantly higher (P < 0.001), among Koreans aged 11 to 40 years. The seroprevalence of anti-HAV IgM significantly differed according to region but not by referral date.
  
  
  CONCLUSIONS
  This was the largest nationwide study in South Korea by 1 laboratory, and it provides useful recent baseline data on hepatitis A in Asia. The findings suggest that active immunization of younger Koreans should be made a priority.
authors: Eone Reference Laboratory, Seoul, South Korea.
authors: Sung Eun
authors: SE
authors: Cho
authors: Youngdae
authors: Y
authors: Kim
mesh_terms: D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D015415:Biomarkers / Q000097:blood; D002648:Child; D002675:Child, Preschool; D005260:Female; D006506:Hepatitis A / Q000453:epidemiology*; D035922:Hepatitis A Antibodies / Q000097:blood*; D030041:Hepatitis A virus / Q000276:immunology / Q000302:isolation & purification*; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D007223:Infant; D008297:Male; D008875:Middle Aged; D056910:Republic of Korea / Q000453:epidemiology; D016036:Seroepidemiologic Studies; D055815:Young Adult
chemical_list: D015415:Biomarkers; D035922:Hepatitis A Antibodies; D007075:Immunoglobulin M
references: World J Gastroenterol. 2010 Mar 7;16(9):1115-8
references: 20205283
references: Jpn J Infect Dis. 2010 May;63(3):192-4
references: 20495272
references: Korean J Hepatol. 2009 Dec;15(4):438-45
references: 20037262
references: Korean J Hepatol. 2007 Sep;13(3):363-9
references: 17898552
references: Clin Microbiol Rev. 2001 Jan;14(1):38-58
references: 11148002
references: Jpn J Infect Dis. 2008 May;61(3):239-41
references: 18503182
references: Vaccine. 2000 Feb 18;18 Suppl 1:S61-4
references: 10683551
references: Korean J Lab Med. 2009 Dec;29(6):563-9
references: 20046089
references: Am Fam Physician. 2006 Jun 15;73(12):2162-8
references: 16848078
references: J Korean Med Sci. 2007 Jun;22(3):546-8
references: 17596668
references: Gut Liver. 2010 Jun;4(2):207-11
references: 20559523
references: Intervirology. 2008;51(2):70-4
references: 18434743
references: J Korean Med Sci. 2007 Apr;22(2):218-22
references: 17449927
references: Korean J Hepatol. 2009 Dec;15 Suppl 6:S7-12
references: 20037282
references: MMWR Recomm Rep. 1999 Oct 1;48(RR-12):1-37
references: 10543657
references: Am J Gastroenterol. 2000 Jan;95(1):223-6
references: 10638588
references: Korean J Hepatol. 2007 Dec;13(4):495-502
references: 18159147